Bon Natural Life Ltd (BON) stock
BONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends September 30
$1.04−0.03 (-2.80%)
Close on Nov 18, 2026Market cap $8.45MP/E –Yield –
Bon Natural Life revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $18.67M, down 21.7% from the year before. The highest annual figure on record is $29.91M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $18.67M | -21.7% |
| FY2024 | Sep 30, 2024 | $23.84M | -19.2% |
| FY2023 | Sep 30, 2023 | $29.52M | -1.3% |
| FY2022 | Sep 30, 2022 | $29.91M | +17.3% |
| FY2021 | Sep 30, 2021 | $25.49M | +39.9% |
| FY2020 | Sep 30, 2020 | $18.22M | +11.1% |
| FY2019 | Sep 30, 2019 | $16.40M | – |
See a number that looks wrong?